Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G.K. Khurana Hershey is active.

Publication


Featured researches published by G.K. Khurana Hershey.


American Journal of Respiratory and Critical Care Medicine | 2017

Effects of Omalizumab on Rhinovirus Infections, Illnesses, and exacerbations of asthma

Ann Esquivel; William W. Busse; Agustin Calatroni; Alkis Togias; Kristine G. Grindle; Yury A. Bochkov; Rebecca S. Gruchalla; Meyer Kattan; Carolyn M. Kercsmar; G.K. Khurana Hershey; Haejin Kim; Petra LeBeau; Andrew H. Liu; Stanley J. Szefler; Stephen J. Teach; Joseph B. West; Jeremy Wildfire; Jaqueline A. Pongracic; James E. Gern

Rationale: Allergic inflammation has been linked to increased susceptibility to viral illnesses, but it is unclear whether this association is causal. Objectives: To test whether omalizumab treatment to reduce IgE would shorten the frequency and duration of rhinovirus (RV) illnesses in children with allergic asthma. Methods: In the PROSE (Preventative Omalizumab or Step‐up Therapy for Severe Fall Exacerbations) study, we examined children with allergic asthma (aged 6‐17 yr; n = 478) from low‐income census tracts in eight U.S. cities, and we analyzed virology for the groups randomized to treatment with guidelines‐based asthma care (n = 89) or add‐on omalizumab (n = 259). Weekly nasal mucus samples were analyzed for RVs, and respiratory symptoms and asthma exacerbations were recorded over a 90‐day period during the fall seasons of 2012 or 2013. Adjusted illness rates (illnesses per sample) by treatment arm were calculated using Poisson regression. Measurements and Main Results: RVs were detected in 97 (57%) of 171 exacerbation samples and 2,150 (36%) of 5,959 nonexacerbation samples (OR, 2.32; P < 0.001). Exacerbations were significantly associated with detection of rhinovirus C (OR, 2.85; P < 0.001) and rhinovirus A (OR, 2.92; P < 0.001), as well as, to a lesser extent, rhinovirus B (OR, 1.98; P = 0.019). Omalizumab decreased the duration of RV infection (11.2 d vs. 12.4 d; P = 0.03) and reduced peak RV shedding by 0.4 log units (95% confidence interval, −0.77 to −0.02; P = 0.04). Finally, omalizumab decreased the frequency of RV illnesses (risk ratio, 0.64; 95% confidence interval, 0.49‐0.84). Conclusions: In children with allergic asthma, treatment with omalizumab decreased the duration of RV infections, viral shedding, and the risk of RV illnesses. These findings provide direct evidence that blocking IgE decreases susceptibility to RV infections and illness. Clinical trial registered with www.clinicaltrials.gov (NCT01430403).


Clinical & Experimental Allergy | 2014

Duration of day care attendance during infancy predicts asthma at the age of seven: the Cincinnati Childhood Allergy and Air Pollution Study

G. Cheng; Andrew M. Smith; Linda Levin; Tolly Epstein; Patrick H. Ryan; Grace K. LeMasters; G.K. Khurana Hershey; Tiina Reponen; Manuel Villareal; James E. Lockey; David I. Bernstein

Studies vary with respect to the reported effects of day care attendance on childhood asthma.


Allergy | 2015

Genetic approach identifies distinct asthma pathways in overweight vs normal weight children

M. Butsch Kovacic; Lisa J. Martin; J. M. Biagini Myers; Hua He; Mark Lindsey; Tesfaye B. Mersha; G.K. Khurana Hershey

The pathogenesis of asthma in the context of excess body weight may be distinct from asthma that develops in normal weight children. The studys objective was to explore the biology of asthma in the context of obesity and normal weight status using genetic methodologies. Associations between asthma and SNPs in 49 genes were assessed, as well as, interactions between SNPs and overweight status in child participants of the Greater Cincinnati Pediatric Clinic Repository. Asthma was significantly associated with weight (OR = 1.38; P = 0.037). The number of genes and the magnitude of their associations with asthma were notably greater when considering overweight children alone vs normal weight and overweight children together. When considering weight, distinct sets of asthma‐associated genes were observed, many times with opposing effects. We demonstrated that the underlying heterogeneity of asthma is likely due in part to distinct pathogenetic pathways that depend on preceding/comorbid overweight and/or allergy. It is therefore important to consider both obesity and asthma when conducting studies of asthma.


Pharmacogenomics Journal | 2015

N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort.

Grace K. LeMasters; G.K. Khurana Hershey; Umasundari Sivaprasad; Lisa J. Martin; Valentina Pilipenko; Mark B. Ericksen; Jeffrey Burkle; Mark Lindsey; David I. Bernstein; James E. Lockey; Joey Gareri; Angelika Lubetsky; Gideon Koren; J. M. Biagini Myers

Cotinine is a proxy for secondhand smoke (SHS) exposure. Genetic variation along nicotine and cotinine metabolic pathways may alter the internal cotinine dose, leading to misinterpretations of exposure-health outcome associations. Caucasian children with available SHS exposure and hair cotinine data were genotyped for metabolism-related genes. SHS-exposed children had 2.4-fold higher hair cotinine (0.14±0.22 ng mg−1) than unexposed children (0.06±0.05 ng mg−1, P<0.001). SHS-exposed children carrying the NAT1 minor allele had twofold higher hair cotinine (0.18 ng mg−1 for heterozygotes and 0.17 ng mg−1 for homozygotes) compared with major allele homozygotes (0.09 ng mg−1, P=0.0009), even after adjustment for SHS dose. These findings support that NAT1 has a role in the metabolic pathway of nicotine/cotinine and/or their metabolites. The increased cotinine levels observed for those carrying the minor allele may lead to SHS exposure misclassification in studies utilizing cotinine as a biomarker. Additional studies are required to identify functional single-nucleotide polymorphism(s) (SNP(s)) in NAT1 and elucidate the biological consequences of the mutation(s).


PLOS ONE | 2017

Endotypes of difficult-to-control asthma in inner-city African American children.

K. R. Brown; Rebecca Z. Krouse; Agustin Calatroni; Cynthia M. Visness; U. Sivaprasad; C. M. Kercsmar; Elizabeth C. Matsui; Joseph B. West; Melanie M. Makhija; Michelle A. Gill; Haejin Kim; Meyer Kattan; Dinesh K. Pillai; James E. Gern; William W. Busse; Alkis Togias; A.H. Liu; G.K. Khurana Hershey

African Americans have higher rates of asthma prevalence, morbidity, and mortality in comparison with other racial groups. We sought to characterize endotypes of childhood asthma severity in African American patients in an inner-city pediatric asthma population. Baseline blood neutrophils, blood eosinophils, and 38 serum cytokine levels were measured in a sample of 235 asthmatic children (6–17 years) enrolled in the NIAID (National Institute of Allergy and Infectious Diseases)-sponsored Asthma Phenotypes in the Inner City (APIC) study (ICAC (Inner City Asthma Consortium)-19). Cytokines were quantified using a MILLIPLEX panel and analyzed on a Luminex analyzer. Patients were classified as Easy-to-Control or Difficult-to-Control based on the required dose of controller medications over one year of prospective management. A multivariate variable selection procedure was used to select cytokines associated with Difficult-to-Control versus Easy-to-Control asthma, adjusting for age, sex, blood eosinophils, and blood neutrophils. In inner-city African American children, 12 cytokines were significant predictors of Difficult-to-Control asthma (n = 235). CXCL-1, IL-5, IL-8, and IL-17A were positively associated with Difficult-to-Control asthma, while IL-4 and IL-13 were positively associated with Easy-to-Control asthma. Using likelihood ratio testing, it was observed that in addition to blood eosinophils and neutrophils, serum cytokines improved the fit of the model. In an inner-city pediatric population, serum cytokines significantly contributed to the definition of Difficult-to-Control asthma endotypes in African American children. Mixed responses characterized by TH2 (IL-5) and TH17-associated cytokines were associated with Difficult-to-Control asthma. Collectively, these data may contribute to risk stratification of Difficult-to-Control asthma in the African American population.


The Journal of Allergy and Clinical Immunology | 2003

The −159 C→T polymorphism of CD14 is associated with nonatopic asthma and food allergy☆☆☆

Jessica G. Woo; Amal H. Assa'ad; A. Heizer; G.K. Khurana Hershey


The Journal of Allergy and Clinical Immunology | 2009

Expression of Cilia Structural Genes is Downregulated in Asthma and Single Nucleotide Polymorphisms in These Genes Correlate with Asthma

Umasundari Sivaprasad; Aaron M. Gibson; Ning Wang; G.K. Khurana Hershey


The Journal of Allergy and Clinical Immunology | 2003

Arginine 27, a conserved methylation site in Stat6, is essential for IL-4-induced tyrosine-phosphorylation, DNA binding activity, and nuclear translocation of Stat6

Weiguo Chen; Michael O. Daines; G.K. Khurana Hershey


The Journal of Allergy and Clinical Immunology | 2012

Diesel Exhaust Particles Induce Cysteine Oxidation and S-Glutathionylation in House Dust Mite Induced Murine Asthma

Gwo-Bin Lee; Eric B. Brandt; Aaron M. Gibson; T. D. Le Cras; Lou Ann S. Brown; Anne M. Fitzpatrick; G.K. Khurana Hershey


The Journal of Allergy and Clinical Immunology | 2008

Exposure to Diesel Exhaust Particles and Indoor Endotoxin During Early Childhood Increases the Risk for Persistent Wheeze at Age Three

P.H. Ryan; David I. Bernstein; Linda Levin; Jeffrey Burkle; Manuel Villareal; H. Kalra; James E. Lockey; G.K. Khurana Hershey; Grace K. LeMasters

Collaboration


Dive into the G.K. Khurana Hershey's collaboration.

Top Co-Authors

Avatar

Michael O. Daines

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Weiguo Chen

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aaron M. Gibson

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

M.R. Warrier

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuhiro Tabata

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mark B. Ericksen

Boston Children's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge